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background: SCD is a leading cause of cardiac mortality in patients with cardiomyopathy (CM). ACEi/ARB antagonize the action of angiotensin-II, 
a known precursor of interstitial fibrosis associated with ventricular arrhythmia. While ACEi/ARB decrease mortality, their role in preventing SCD in 
patients with CM has not been well established.
Methods: We identified consecutive patients with CM who had ICD from the prospective NIH-sponsored (GRADE)multicenter study. Patients were 
stratified whether or not they were taking ACEi/ARB and were matched using propensity method. Patients had device interrogation every 6 months. 
Time to appropriate shock was the primary endpoint.
results: There were 1509 patients (age 63±12 years, 80% male, EF 21±6%) with 1213 on ACEi/ARB. We identified 574 propensity matched 
patients (287 in each group). After a mean of 2.5 ±1.9 years, there were 334 appropriate shocks. The use of ACEi/ARB was associated with lower 
incidence of shocks with relative risk 0.66 [0.52;0.85] (unmatched cohort) and 0.61[0.43;0.86] (matched cohort) [Figure 1]. On multivariate 
analysis, ACEi/ARB were associated with 40% reduction in incidence of appropriate shock (HR 0.57 [0.41-0.81]) in the propensity matched cohort. 
The NNT to prevent appropriate shocks at 1,3 and 5 years were 19, 10 and 7, respectively.
conclusion: ACEi/ARB are associated with ≈ 40% lower incidence of appropriate ICD shock in patients with CM. The effect persisted after 
propensity matching.
 
